Senior Manager - Market Access Strategy

Senior Manager - Market Access

ROLE SUMMARY

The Senior Manager – Market Access is the Engine Room of Pfizer India's institutional reimbursement strategy. This role owns the evidence, economic, and access-design machinery that enables the Policy and GKAM functions to operate with credibility and force. Operating across Pfizer India's priority portfolio — Lorlatinib, Elranatamab, PCV20, Nurtec, Hympavzi, and Genryzon — the incumbent architects the HEOR models, partnership structures, and PAP/managed-entry designs that justify and sustain reimbursement across ESIC, state government programs, central federal accounts (CGHS, AFMS, Railways, AGIs), and private channels.

 

The role demands deep strategic autonomy, cross-functional alignment, and the ability to translate complex clinical and economic evidence into institutional access wins

ROLE RESPONSIBILITIES

1. Health Economics, Evidence & Value Strategy

Lead development and deployment of the full suite of access evidence: cost-effectiveness models, budget impact analyses (BIM), cost-offset models (in-house vs. SST referral), state budget liability models for rare disease, and disease burden frameworks. Produce and socialize localized HEOR outputs — including CEA studies and publications — calibrated to specific payer audiences (ESIC, state health assurance agencies, NTAGI, army/railway medical boards). Ensure India's HEOR strategy is aligned with global HEOR priorities and adapted for local institutional decision-making logic

2. Access Partnership Design

Design and oversee access partnerships with diagnostic providers, vaccination program implementers, and healthcare ecosystem players — specifically where partnerships strengthen institutional capacity and create demand pull for Pfizer's portfolio. This includes diagnostic capability enhancement partnerships (e.g., ALK/BCMA testing within ESIC hospitals for Lorlatinib and Elranatamab), and programmatic vaccination implementation partnerships covering hesitancy, inoculation logistics, data recording, and impact evidence for PCV20.

3. PAP Architecture & Managed Entry Design

Architect innovative patient access programs and managed entry agreements tailored to institutional purchasing mechanisms. This includes: 1+1 cycle-based PAPs for Central Rate Contract submissions (Army/Railway/CGHS) that reduce effective government cost without impacting global invoice price; patient-capped PAPs for ESIC Local Purchase / Special Sanction routes that guarantee Medical Superintendents fixed maximum liability per patient per year; and Annual-Cap structures for rare disease state co-funding (Hympavzi/Genryzon) that give state finance departments predictable exposure. Design covers financial modelling, structure, and governance; scheme execution and supply-side coordination sits with GKAM and Finance.

4. Account-Level Access Strategy

Develop and own the access strategy for the assigned account cluster — either States (NHM, Ayushman, state health assurance schemes) or Federal/AGI accounts (ESIC, CGHS, AFMS, Railways, AGIs) — working in tight coordination with the GKAM and Policy leads. Responsibilities include account prioritization, reimbursement pathway mapping, formulary and RC inclusion strategy, and the design of access models specific to each account's procurement logic. Execution activities — RC/PO management, file co-creation, procurement follow-through — are GKAM responsibilities and are not within this role's scope.

5.  Cross-Functional Access Integration

Serve as the primary Market Access interface for Medical, HEOR, Government Affairs, Commercial, and above-country teams. Ensure access evidence and program designs are developed in tight coordination with Policy (who shapes the environment) and GKAM (who converts accounts), without duplicating or stepping into their functional mandates. Actively contribute to above-country access forums as the India SME on reimbursement evidence and PAP design. Maintain clean hand-off protocols between Access, Policy, and GKAM to preserve the integrity of the unified triad structure defined in the reimbursement blueprint.

QUALIFICATIONS

• Science graduate with MBA (or equivalent postgraduate management qualification) from a reputed institution; additional certification in Health Economics or Health Policy is advantageous.
• undefined
• 10+ years of experience in Market Access, Key Accounts, or Health Economics roles within the pharmaceutical, biotech, or healthcare consulting sector; with demonstrated progression in scope and accountability.
• undefined
• Hands-on proficiency in health-economic modelling: BIM, cost-effectiveness / cost-benefit analysis, cost-offset models, and state budget liability modelling for rare diseases. Ability to critically direct and review HEOR outputs independently and translate them into audience-specific institutional narratives.
• undefined
• Demonstrated experience designing PAPs and managed entry agreements for institutional accounts — including cycle-based RC PAPs, patient-capped local purchase structures, and co-funding models — with working knowledge of General Financial Rules (GFR), ESIC procurement processes, and state NHM/Ayushman scheme structures.
• undefined
• Experience designing or managing access partnerships with diagnostic providers, vaccination implementers, or ecosystem players in the public health space.
• undefined
• Deep familiarity with India's priority reimbursement accounts: ESIC, CGHS, AFMS, Railways, state health assurance agencies, and AGIs. Proven track record of formulary inclusions, RC listings, or funded programme wins in at least two of these account types.
• undefined Ability to operate in a matrix organization with clear functional boundaries — coordinating tightly with Policy (environment shaping) and GKAM (account execution) without role overlap.

ORGANIZATIONAL RELATIONSHIPS

• Internal: Medical Affairs, HEOR, Government Affairs / Public Policy, GKAM, Commercial/Marketing, Finance, Pricing, New Products Planning, India Leadership Team, Global Access & Pricing (GAV), Regional Market Access.
• External (access & evidence interface only): ESIC/CGHS programme offices, state health assurance agency technical teams, NTAGI working group members (evidence-sharing), diagnostic and vaccination implementation partners, private hospital access leads.

Note: Senior stakeholder engagement with government political leadership, Chief Ministers, DG-ESIC, NGOs, and patient advocacy groups is owned by the Public Policy function. GKAM owns RC/PO execution, special sanction facilitation, and MoHFW portal submissions.

RESOURCES MANAGED

Financial Accountability: Manage assigned programme and access initiative budgets, including HEOR evidence generation, partnership design, and PAP/managed entry programme costs.

Supervision: Matrix leadership responsibility. No Direct reports

Work Location Assignment: Hybrid

Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.

To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers.

Market Access

Experience Level

Senior Level